French Drugmaker Says World's First Dengue Fever Vaccine Ready Next Year Health24
go to original September 3, 2014

Employees work in the cell-culture unit at the French drug maker Sanofi Pasteur's vaccine unit plant in Neuville-sur-Saone, near Lyon. (Reuters)

French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 percent in a large final clinical trial.

Sanofi has invested more than 1.3 billion euros ($1.7 billion) in the project, undertaking two decades of research on the world's fastest-growing tropical disease.

The final study – conducted on 20,875 children aged 9-16 across five countries in Latin America – confirmed that the vaccine was safe, provided high protection against dengue hemorrhagic fever and cut by 80 percent the risk of hospitalization, according to the Paris-based company

...The study was conducted in Brazil, Colombia, Mexico, Honduras and Puerto Rico. Sanofi will unveil its detailed findings at the American Society of Tropical Medicine and Hygiene's annual meeting at the beginning of November.

Read the rest at Health24

We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!